Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Weir

Showing results (41-50 of 419) with videos related to

Pageof 42
Sort By:
Postgraduate Medicine|January 30, 2016
The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitorsMatthew R Weir
Journal of Diabetes|May 9, 2019
Predicting, preventing, and managing cardiovascular and chronic kidney disease progression in people with type 2 diabetes: How to improve on traditional strategiesMatthew R Weir
Postgraduate Medicine|June 4, 2009
Beta-blockers in the treatment of hypertension: are there clinically relevant differences?Matthew R Weir
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2009
Hypertension and the kidney: perspectives on the relationship of kidney disease and cardiovascular diseaseMatthew R Weir
Current Hypertension Reports|September 9, 2008
Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?Matthew R Weir
Current Hypertension Reports|September 10, 2002
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockersMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Optimal treatment strategies for patients with hypertension and diabetes: are effects on metabolism important?Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
How Low Should We Treat Blood Pressure and Why?Matthew R. Weir
Kidney International Supplements|January 25, 2019
Current and future treatment options for managing hyperkalemiaMatthew R Weir
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Blood pressure salt sensitivity: a biomeasure of kidney disease susceptibility in diabetics?Matthew R Weir
Pageof 42

Showing results (41-50 of 419) with videos related to

Sort By:
Pageof 42
Postgraduate Medicine|January 30, 2016
The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitorsMatthew R Weir
Journal of Diabetes|May 9, 2019
Predicting, preventing, and managing cardiovascular and chronic kidney disease progression in people with type 2 diabetes: How to improve on traditional strategiesMatthew R Weir
Postgraduate Medicine|June 4, 2009
Beta-blockers in the treatment of hypertension: are there clinically relevant differences?Matthew R Weir
Clinical Journal of the American Society of Nephrology : CJASN|July 18, 2009
Hypertension and the kidney: perspectives on the relationship of kidney disease and cardiovascular diseaseMatthew R Weir
Current Hypertension Reports|September 9, 2008
Are we "ONTARGET" yet with regard to optimal antihypertensive regimens?Matthew R Weir
Current Hypertension Reports|September 10, 2002
Opportunities for cardiovascular risk reduction with angiotensin II receptor blockersMatthew R Weir
Hypertension (Dallas, Tex. : 1979)|September 21, 2011
Optimal treatment strategies for patients with hypertension and diabetes: are effects on metabolism important?Matthew R Weir
Journal of Clinical Hypertension (Greenwich, Conn.)|June 21, 2001
How Low Should We Treat Blood Pressure and Why?Matthew R. Weir
Kidney International Supplements|January 25, 2019
Current and future treatment options for managing hyperkalemiaMatthew R Weir
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 21, 2005
Blood pressure salt sensitivity: a biomeasure of kidney disease susceptibility in diabetics?Matthew R Weir
Pageof 42